Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)

BMC Immunology

Volumn 8, Issue , 2007, Pages

  Saban, Marcia R ^a   Simpson, Cindy ^a   Davis, Carole ^a   Wallis, Gemma ^b   Knowlton, Nicholas ^b   Frank, Mark Barton ^b   Centola, Michael ^b   Gallucci, Randle M ^c   Saban, Ricardo ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHEMOKINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17A; INTERLEUKIN 17A RECEPTOR; INTERLEUKIN 17B; INTERLEUKIN 17B RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; KERATINOCYTE DERIVED CHEMOKINE; LIPOPOLYSACCHARIDE; RANTES; THERACYS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; CYSTITIS; CYTOKINE RELEASE; DOSAGE SCHEDULE COMPARISON; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GENE EXPRESSION REGULATION; GRANULOMA; HISTOPATHOLOGY; INFLAMMATORY CELL; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN URINE LEVEL; TOXICITY TESTING; UPREGULATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHROMATIN IMMUNOPRECIPITATION; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INTRAVESICAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; ULTRASTRUCTURE; URINE;

ADMINISTRATION, INTRAVESICAL; ANIMALS; BCG VACCINE; CHROMATIN IMMUNOPRECIPITATION; CYSTITIS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GRANULOMA; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NEUTROPHILS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; URINARY BLADDER;

EID: 34250661461     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-8-6     Document Type: Article

References (59)

1. Peters KM Diokno AC Steinert BW Preliminary study on urinary cytokine levels in interstitial cystitis: Does intravesical bacille Calmette-Guerin treat interstitial cystitis by altering the immune profile in the bladder? Urology 1999 54 3 450-453 10.1016/ S0090-4295(99)00162-4 10475352
2. Huben RP Intravesical chemotherapy versus immunotherapy for superficial bladder cancer Semin Urol Oncol 1996 14 1 Suppl 1 17-22 8727806
3. De Jager R Guinan P Lamm D Khanna O Brosman S De Kernion J Williams R Richardson C Muenz L Reitsma D Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials Urology 1991 38 6 507-513 10.1016/0090-4295(91)80166-5 1836081
4. Alexandroff AB Jackson AM O'Donnell MA James K BCG immunotherapy of bladder cancer: 20 years on Lancet 1999 353 9165 1689-1694 10.1016/ S0140-6736(98)07422-4 10335805
5. Grossman HB Superficial bladder cancer: Decreasing the risk of recurrence Oncology (Huntingt) 1996 10 11 1617-1624 discussion 1624, 1627-1618.
6. Mitropoulos DN Novel insights into the mechanism of action of intravesical immunomodulators In Vivo 2005 19 3 611-621 15875784
7. Decobert M Larue H Bergeron A Harel F Pfister C Rousseau F Lacombe L Fradet Y Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer J Urol 2006 175 4 1506-1511 10.1016/S0022-5347(05)00653-1 16516037
8. O'Donnell M Entrez into the immunogenetics of superficial bladder cancer response to bacillus Calmette-Guerin J Urol 2006 175 4 1197-1198 10.1016/ S0022-5347(06)00054-1 16515958
9. Bevers RF Kurth KH Schamhart DH Role of urothelial cells in BCG immunotherapy for superficial bladder cancer Br J Cancer 2004 91 4 607-612 15266312
10. Abadie V Badell E Douillard P Ensergueix D Leenen PJ Tanguy M Fiette L Saeland S Gicquel B Winter N Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes Blood 2005 106 5 1843-1850 10.1182/ blood-2005-03-1281 15886329
11. Schamhart DH Kurth KH de Reijke TM Vleeming R BCG treatment and the importance of an inflammatory response Urol Res 1992 20 3 199-203 10.1007/BF00299717 1615581
12. Zhang G Chen F Xu Y Cao Y Crist S McKerrow A Iwamoto Y See WA Autocrine over expression of fibronectin by human transitional carcinoma cells impairs bacillus Calmette-Guerin adherence and signaling J Urol 2004 172 4 Pt 1 1496-1500 10.1097/01.ju.0000140193.95528.91 15371878
13. Atkins H Davies BR Kirby JA Kelly JD Polarisation of a T-helper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides: A potential therapeutic regime for bladder cancer immunotherapy Br J Cancer 2003 89 12 2312-2319 10.1038/sj.bjc.6601474 14676812
14. Akazawa T Masuda H Saeki Y Matsumoto M Takeda K Tsujimura K Kuzushima K Takahashi T Azuma I Akira S Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice Cancer Res 2004 64 2 757-764 10.1158/0008-5472.CAN-03-1518 14744795
15. Li X Gong ZY Li H Wei Q Shi M Yang YR [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell] Zhonghua Wai Ke Za Zhi 2004 42 3 177-181 15062066
16. Patard JJ Guille F Lobel B Abbou CC Chopin D [Current state of knowledge concerning the mechanisms of action of BCG] Prog Urol 1998 8 3 415-421 9689679
17. Ludwig AT Moore JM Luo Y Chen X Saltsgaver NA O'Donnell MA Griffith TS Tumor necrosis factor-related apoptosis-inducing ligand: A novel mechanism for Bacillus Calmette-Guerin-induced antitumor activity Cancer Res 2004 64 10 3386-3390 10.1158/0008-5472.CAN-04-0374 15150089
18. Nardini E Morelli D Aiello P Besusso D Calcaterra C Mariani L Palazzo M Vecchi A Paltrinieri S Menard S CpG-oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL-8) production J Cell Physiol 2005 204 889-895 10.1002/jcp.20360 15828023
19. De Boer EC Rooijakkers SJ Schamhart DH Kurth KH Cytokine gene expression in a mouse model: The first instillations with viable bacillus Calmette-Guerin determine the succeeding Th1 response J Urol 2003 170 5 2004-2008 10.1097/01.ju.0000091826.83705.79 14532842
20. Saban MR Nguyen NB Hurst RE Saban R Gene expression profiling of inflammatory bladder disorders Expert Rev Mol Diagn 2003 3 2 217-235 10.1586/14737159.3.2.217 12647997
21. Gonzalez RR Fong T Belmar N Saban M Felsen D Te A Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis J Urol 2005 173 2 630-634 10.1097/01.ju.0000143192.68223.f7 15643278
22. Adams DO The granulomatous inflammatory response. A review Am J Pathol 1976 84 1 164-191 937513
23. Saban MR Saban R Hammond TG Haak-Frendscho M Steinberg H Tengowski MW Bjorling DE LPS-sensory peptide communication in experimental cystitis Am J Physiol Renal Physiol 2002 282 2 F202-210 11788433
24. Saban MR Nguyen NB Hammond TG Saban R Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation Am J Pathol 2002 160 6 2095-2110 12057914
25. O'Donnell MA Luo Y Chen X Szilvasi A Hunter SE Clinton SK Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guerin J Immunol 1999 163 8 4246-4252 10510362
26. Anderson GG Palermo JJ Schilling JD Roth R Heuser J Hultgren SJ Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections Science 2003 301 5629 105-107 10.1126/science.1084550 12843396
27. Peuchmaur M Benoit G Vieillefond A Chevalier A Lemaigre G Martin ED Jardin A Analysis of mucosal bladder leucocyte subpopulations in patients treated with intravesical Bacillus Calmette-Guerin Urol Res 1989 17 5 299-303 10.1007/BF00262987 2683316
28. Prescott S James K Hargreave TB Chisholm GD Smyth JF Intravesical Evans strain BCG therapy: Quantitative immunohistochemical analysis of the immune response within the bladder wall J Urol 1992 147 6 1636-1642 1593713
29. Ratliff TL Ritchey JK Yuan JJ Andriole GL Catalona WJ T-cell subsets required for intravesical BCG immunotherapy for bladder cancer J Urol 1993 150 3 1018-1023 8102183
30. Siracusano S Vita F Abbate R Ciciliato S Borelli V Bernabei M Zabucchi G The Role of Granulocytes Following Intravesical BCG Prophylaxis Eur Urol 2006 51 6 1589-1599 10.1016/j.eururo.2006.11.045 17222501
31. Suttmann H Riemensberger J Bentien G Schmaltz D Stockle M Jocham D Bohle A Brandau S Neutrophil granulocytes are required for effective bacillus calmette-guerin immunotherapy of bladder cancer and orchestrate local immune responses Cancer Res 2006 66 16 8250-8257 10.1158/ 0008-5472.CAN-06-1416 16912205
32. Geisel RE Sakamoto K Russell DG Rhoades ER In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates J Immunol 2005 174 8 5007-5015 15814731
33. Bohle A Gerdes J Ulmer AJ Hofstetter AG Flad HD Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall J Urol 1990 144 1 53-58 2359181
34. Hasan Z Zaidi I Jamil B Khan MA Kanji A Hussain R Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis BMC Immunol 2005 6 14 1182368 16001981 10.1186/1471-2172-6-14
35. Olleros ML Guler R Vesin D Parapanov R Marchal G Martinez-Soria E Corazza N Pache JC Mueller C Garcia I Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections Am J Pathol 2005 166 4 1109-1120 1602380 15793291
36. Guler R Olleros ML Vesin D Parapanov R Garcia I Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection Infect Immun 2005 73 6 3668-3676 1111814 15908396 10.1128/IAI.73.6.3668-3676.2005
37. Nadler R Luo Y Zhao W Ritchey JK Austin JC Cohen MB O'Donnell MA Ratliff TL Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guerin (BCG) mediated antitumour activity Clin Exp Immunol 2003 131 2 206-216 10.1046/ j.1365-2249.2003.02071.x 12562379
38. Saban MR Saban R Bjorling D Haak-Frendscho M Involvement of leukotrienes, TNF-alpha, and the LFA-1/ICAM-1 interaction in substance P-induced granulocyte infiltration J Leukoc Biol 1997 61 4 445-451 9103231
39. Walz A Kunkel SLRMS C-X-C Chemokines-an overview Chemokines in Disease Austin: R. G. Landes Koch AE, Strieter RM 1-25
40. Kawaguchi M Adachi M Oda N Kokubu F Huang SK IL-17 cytokine family J Allergy Clin Immunol 2004 114 6 1265-1273 quiz 1274 10.1016/ j.jaci.2004.10.019 15577820
41. Kolls JK Linden A Interleukin-17 family members and inflammation Immunity 2004 21 4 467-476 10.1016/j.immuni.2004.08.018 15485625
42. Takahashi H Numasaki M Lotze MT Sasaki H Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells Immunol Lett 2005 98 2 189-193 10.1016/j.imlet.2004.11.012 15860217
43. Umemura M Kawabe T Shudo K Kidoya H Fukui M Asano M Iwakura Y Matsuzaki G Imamura R Suda T Involvement of IL-17 in Fas ligand-induced inflammation Int Immunol 2004 16 8 1099-1108 10.1093/intimm/dxh111 15237105
44. Laan M Cui ZH Hoshino H Lotvall J Sjostrand M Gruenert DC Skoogh BE Linden A Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways J Immunol 1999 162 4 2347-2352 9973514
45. Heninger E Hogan LH Karman J Macvilay S Hill B Woods JP Sandor M Characterization of the Histoplasma capsulatum-induced granuloma J Immunol 2006 177 5 3303-3313 16920971
46. Hubeau C Singer M Lagranderie M Marchal G Vargaftig B Extended freeze-dried Mycobacterium bovis Bacillus Calmette-Guerin induces the release of interleukin-12 but not tumour necrosis factor-alpha by alveolar macrophages, both in vitro and in vivo Clin Exp Allergy 2003 33 3 386-393 10.1046/j.1365-2222.2003.01612.x 12614454
47. de Boer EC Rooyakkers SJ Schamhart DH de Reijke TM Kurth KH BCG Dose Reduction by Decreasing the Instillation Frequency: Effects on Local Th1/ Th2 Cytokine Responses in a Mouse Model Eur Urol 2005 15963631
48. Patard JJ Muscatelli-Groux B Saint F Popov Z Maille P Abbou C Chopin D Evaluation of local immune response after intravesical bacille Calmette-Guerin treatment for superficial bladder cancer Br J Urol 1996 78 5 709-714 8976765
49. Poppas DP Pavlovich CP Folkman J Voest EE Chen X Luster AD O'Donnell MA Intravesical bacille Calmette-Guerin induces the antiangiogenic chemokine interferon-inducible protein 10 Urology 1998 52 2 268-275 discussion 275-266. 10.1016/S0090-4295(98)00188-5 9697793
50. Lotz M Villiger P Hugli T Koziol J Zuraw BL Interleukin-6 and interstitial cystitis J Urol 1994 152 3 869-873 8051739
51. Erickson DR Xie SX Bhavanandan VP Wheeler MA Hurst RE Demers LM Kushner L Keay SK A comparison of multiple urine markers for interstitial cystitis J Urol 2002 167 6 2461-2469 10.1016/S0022-5347(05)65005-7 11992058
52. Erickson DR Urine markers of interstitial cystitis Urology 2001 57 6 Suppl 1 15-21 10.1016/S0090-4295(01)01128-1 11378044
53. Saban MR Saban R Hammond TG Haak-Frendscho M Steinberg H Tengowski MW Bjorling DE LPS-sensory peptide communication in experimental cystitis Am J Physiol-Renal 2002 282 2 F202-F210
54. Saban R Gerard NP Saban MR Nguyen NB DeBoer DJ Wershil BK Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism Am J Physiol Renal Physiol 2002 283 4 F616-629 12217852
55. Saban MR Hellmich H Nguyen NB Winston J Hammond TG Saban R Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation Physiol Genomics 2001 5 3 147-160 11285368
56. http://www.genpathway.com
57. Labhart P Karmakar S Salicru EM Egan BS Alexiadis V O'Malley BW Smith CL Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator Proc Natl Acad Sci USA 2005 102 5 1339-1344 547886 15677324 10.1073/pnas.0409578102
58. http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi
59. Littell R Milliken G Stroup W Wolfinger R Schabenberger O SAS for Mixed Models Cary, NC 2006: SAS Institute Inc Second 2006